Skip to content

ZOGENIX, INC.

Delisted

CIK 1375151fmd_0FX64T9QQEPJGNDR99N6D9W25QManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Dec 31, 2021, 48 periods

Latest annual · FY2021

Millions
Total revenues
82
Gross profit
77
Operating income
(224)
Net income
(227)
Free cash flow
(185)

Latest quarter · Q4 FY2021

Millions
Total revenues
27
Operating income
(63)
Net income
(55)
Free cash flow
(41)

Bulls and bears

Loading

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
n/m
Revenue, 5 yearsFY2016 to FY2021
+23.1%
Net income, 5 yearsFY2016 to FY2021
n/m

ZOGENIX, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$81.7 million$13.6 million+498.8%10-K 2022-03-01 · proof
Gross profit$76.9 million$13.1 million+486.6%10-K 2022-03-01 · proof
Operating income-$224.1 million-$247.7 million10-K 2022-03-01 · proof
Net income-$227.4 million-$209.4 million10-K 2022-03-01 · proof
Cash from operating activities-$185.3 million-$167.5 million10-K 2022-03-01 · proof
Free cash flow-$185.4 million-$168.2 million10-K 2022-03-01 · proof
Total assets$468.5 million$651.1 million-28%10-K 2022-03-01 · proof
Total liabilities$289.5 million$281.5 million+2.9%10-K 2022-03-01 · proof
Cash and cash equivalents$101.2 million$166.9 million-39.4%10-K 2022-03-01 · proof
What was ZOGENIX, INC.'s revenue in fiscal 2021?
ZOGENIX, INC. reported revenue of $81.7 million for fiscal 2021 (the year ended Dec 31, 2021), against $13.6 million the year before (+498.8%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was ZOGENIX, INC.'s gross profit in fiscal 2021?
ZOGENIX, INC. reported gross profit of $76.9 million for fiscal 2021 (the year ended Dec 31, 2021), against $13.1 million the year before (+486.6%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was ZOGENIX, INC.'s operating income in fiscal 2021?
ZOGENIX, INC. reported operating income of -$224.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$247.7 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was ZOGENIX, INC.'s net income in fiscal 2021?
ZOGENIX, INC. reported net income of -$227.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$209.4 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was ZOGENIX, INC.'s cash from operating activities in fiscal 2021?
ZOGENIX, INC. reported cash from operating activities of -$185.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$167.5 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was ZOGENIX, INC.'s free cash flow in fiscal 2021?
ZOGENIX, INC. reported free cash flow of -$185.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$168.2 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What are ZOGENIX, INC.'s total assets?
As of Dec 31, 2021, ZOGENIX, INC. reported total assets of $468.5 million, against $651.1 million a year earlier (-28%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What are ZOGENIX, INC.'s total liabilities?
As of Dec 31, 2021, ZOGENIX, INC. reported total liabilities of $289.5 million, against $281.5 million a year earlier (+2.9%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What are ZOGENIX, INC.'s cash and cash equivalents?
As of Dec 31, 2021, ZOGENIX, INC. reported cash and cash equivalents of $101.2 million, against $166.9 million a year earlier (-39.4%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1375151&period_type=annual&limit=5"

Information only, not investment advice.